Adirondack Funds’s AbbVie ABBV Stock Holding History

Adirondack Funds’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$343K	Buy	+6,300	New	+$410K	0.13%	91

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adirondack Funds's ABBV Position: Q3 2015 in Review

Adirondack Funds opened a new position in AbbVie (ABBV) in Q3 2015: 6,300 shares worth $343K. The stake represents 0.13% of the portfolio and ranks #91 among its holdings.

1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Adirondack Funds held 6,300 shares of AbbVie worth $343K as of Q3 2015.
AbbVie was a new Adirondack Funds position in Q3 2015.
AbbVie made up 0.13% of Adirondack Funds's portfolio in Q3 2015, its #91 holding.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Adirondack Funds's 13F filing for Q3 2015, filed 10 Nov 2015.